Filippo A. Brioschi

Monza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prophylaxis and management of thromboembolism in pnh patients: an italian survey.

Prophylaxis and management of thromboembolism in pnh patients: an italian survey.

Journal: Annals of hematology

Published: February 03, 2026

Clinical heterogeneity and outcome of acquired PRCA: a multicenter European study.

Clinical heterogeneity and outcome of acquired PRCA: a multicenter European study.

Journal: Blood advances

Published: December 24, 2025

Clinical Heterogeneity and Outcome of acquired PRCA: a Multicenter European Study.

Clinical Heterogeneity and Outcome of acquired PRCA: a Multicenter European Study.

Journal: Blood advances

Published: December 24, 2025

Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience.

Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience.

Journal: Platelets

Published: December 06, 2024

Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.

Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.

Journal: British journal of haematology

Published: November 16, 2024

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.

Journal: Blood advances

Published: October 01, 2024

Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.

Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.

Journal: Cancer medicine

Published: September 29, 2022

Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.

Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.

Journal: American journal of hematology

Published: August 06, 2020

Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.

Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.

Journal: Hematological oncology

Published: July 29, 2020

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.

Journal: Hematological oncology

Published: June 23, 2019

An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.

An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.

Journal: Clinical case reports

Published: June 20, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026